National Cancer Institute Thesaurus

Last uploaded: February 23, 2024
Preferred Name

Lucitanib

Synonyms

1-Naphthalenecarboxamide, 6-((7-((1-aminocyclopropyl)methoxy)-6-methoxy-4-quinolinyl)oxy)-n-methyl-

AL3810

E-3810

LUCITANIB

Lucitanib

Definitions

A novel dual inhibitor targeting human vascular endothelial growth factor receptors (VEGFRs) and fibroblast growth factor receptors (FGFRs) with antiangiogenic activity. Lucitanib inhibits VEGFR-1, -2, -3 and FGFR-1, -2 kinases in the nM range, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation, and the induction of tumor cell death. Both VEGFRs and FGFRs belong to the family of receptor tyrosine kinases that may be upregulated in various tumor cell types.

ID

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C95726

CAS_Registry

1058137-23-7

code

C95726

Concept_In_Subset

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157711

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157712

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C128784

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63923

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C177537

Contributing_Source

FDA

GDC

DEFINITION

A novel dual inhibitor targeting human vascular endothelial growth factor receptors (VEGFRs) and fibroblast growth factor receptors (FGFRs) with antiangiogenic activity. Lucitanib inhibits VEGFR-1, -2, -3 and FGFR-1, -2 kinases in the nM range, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation, and the induction of tumor cell death. Both VEGFRs and FGFRs belong to the family of receptor tyrosine kinases that may be upregulated in various tumor cell types.

FDA_UNII_Code

PP449XA4BH

FULL_SYN

1-Naphthalenecarboxamide, 6-((7-((1-aminocyclopropyl)methoxy)-6-methoxy-4-quinolinyl)oxy)-n-methyl-

AL3810

E-3810

LUCITANIB

Lucitanib

Is_Value_For_GDC_Property

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1909

label

Lucitanib

Maps_To

Lucitanib

NCI_Drug_Dictionary_ID

694590

PDQ_Closed_Trial_Search_ID

694590

PDQ_Open_Trial_Search_ID

694590

Preferred_Name

Lucitanib

prefixIRI

Thesaurus:C95726

Semantic_Type

Pharmacologic Substance

UMLS_CUI

C3887575

subClassOf

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C93259

Delete Subject Author Type Created
No notes to display